This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Interstitial Cystitis or Pelvic Pain
and you are
over 18
years old
Phase
-
The phase for this study is not defined.
Show me locations

The purpose

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a poorly understood chronic disorder of unknown etiology consisting of irritative bladder symptoms and pelvic pain that dramatically affects quality of life. Preclinical study data (obtained by using an IC/PBS model in Sprague-Dawley female rats) have demonstrated normalization of urinary frequency indicating that LP may be a potent protectant of the bladder mucosa against inflammation and irritation. Intravesical LP has so far demonstrated an excellent safety profile and minimal toxicity at concentrations of 2 mg/ml. Thus, we hypothesize that intravesical instillation of LP may form a molecular film on bladder ulcer surfaces in patients with IC and provide a safe, effective, and minimally invasive treatment option to alleviating symptoms.

Provided treatments

  • Biological: Liposomes
Tris trial is registered with FDA with number: NCT01731470. The sponsor of the trial is Kenneth Peters, MD and it is looking for 14 volunteers for the current phase.
Official trial title:
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)